HOUSTON COLON FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

ERIC HAAS

Phone

7137900600

Tax Period

2023-01-01 to 2023-12-31

HOUSTON COLON FOUNDATION, founded in 2021, is a small nonprofit in the Medical Research sector that reported $193K in total revenue in fiscal year 2023. Revenue fell 54% from the prior year — a significant decline worth monitoring. Expenses of $181K left a modest 6% surplus.

Mission

THE FOUNDATION WILL CONDUCT RESEARCH AND DEVELOPMENT PROGRAMS TO EVALUATE THE PATIENT BENEFITS OF SEVERAL EMERGING TECHNOLOGIES AND TOOLS IN COLORECTAL SURGERY. THIS RESEARCH WILL BE AIMED AT DEVELOPING AND IMPLEMENTING NEW TECHNOLOGY INTO PRACTICE FOR COLORECTAL SURGEONS, TRAINEES, AND PATIENTS.

Program Service Accomplishments

Program 1

Expenses: $179,408

THE FOUNDATION CONDUCTS RESEARCH TO IMPROVE AND IMPLEMENT NEW TECHNOLOGIES TO ADVANCE TREATMENTS OF COLON AND RECTAL CANCER, DIVERTICULITIS, ULCERATIVE COLITIS, CROHN'S DISEASE, AND OTHER DISEASES OF...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $193,403

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $193,403

Expense Breakdown

Grants Paid $3,000

Salaries & Benefits $99,868

Fundraising Expenses $0

Program Expenses $179,408

Other Expenses $78,560

TOTAL EXPENSES $181,428

Year-over-Year Comparison

	2023	2022	Change
Revenue	$193,403	$420,645	-0.5%
Expenses	$181,428	$114,995	+0.6%
Net Income	$11,975	$305,650	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ERIC HAAS	DIRECTOR & PRESIDENT	1.0	Director	$0	$0	$0
JEAN-PAUL LEFAVE	DIRECTOR & SECRETARY	1.0	Director	$0	$0	$0
JOSHUA COURSEY	DIRECTOR	1.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$193,403	$181,428	$317,625	$11,975
2022	$420,645	$114,995	$305,650	$305,650